Literature DB >> 26523109

Dysbiotic infection in the stomach.

Hisashi Iizasa1, Shyunji Ishihara1, Timmy Richardo1, Yuichi Kanehiro1, Hironori Yoshiyama1.   

Abstract

Microbiota in human alimentary tract plays important roles for homeostatic maintenance of the body. Compositional difference of gut microbiota is tightly associated with susceptibility of many diseases, including inflammatory diseases, obesity, diabetes mellitus, cancer, and atherosclerosis. "Dysbiosis" refers to a state of imbalance among the colonies of microorganisms within the body, which brings abnormal increase of specific minor components and decrease in the normally dominant species. Since stomach secrets strong acid for its digestive role, this organ has long been thought a sterile organ. However, the discovery of Helicobacter pylori (H. pylori) has changed the concept. This bacterium has proven to cause gastritis, peptic ulcer, and gastric cancer. However, recent cross-sectional studies revealed that H. pylori carriers had a decreased risk of developing immunological diseases, such as asthma. H. pylori coinfection also suppresses inflammatory bowel diseases. This review describes human gastric microbiota by discussing its mutual interaction and pathogenic enrollment. Gastric "dysbiosis" may affect host inflammatory response and play important role for gastric pathogenesis. We will topically discuss enrollment of dysbiosis for genesis of gastric cancer as well as for disruption of immunological homeostasis affecting oncogenic resistance.

Entities:  

Keywords:  Dysbiosis; Epstein-Barr virus; Helicobacter pylori; Microbiota; Stomach

Mesh:

Year:  2015        PMID: 26523109      PMCID: PMC4616220          DOI: 10.3748/wjg.v21.i40.11450

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

Review 1.  Unique mechanism of Helicobacter pylori for colonizing the gastric mucus.

Authors:  H Yoshiyama; T Nakazawa
Journal:  Microbes Infect       Date:  2000-01       Impact factor: 2.700

2.  Comparative analysis of gastric bacterial microbiota in Mongolian gerbils after long-term infection with Helicobacter pylori.

Authors:  Takako Osaki; Takahiro Matsuki; Takashi Asahara; Cynthia Zaman; Tomoko Hanawa; Hideo Yonezawa; Satoshi Kurata; Timothy Derg-hoong Woo; Koji Nomoto; Shigeru Kamiya
Journal:  Microb Pathog       Date:  2012-07       Impact factor: 3.738

3.  The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia.

Authors:  Xiaobo Li; Huimin Chen; Hong Lu; Weiguang Li; Xiaoyu Chen; Yansheng Peng; Zhizheng Ge
Journal:  Scand J Gastroenterol       Date:  2010-05       Impact factor: 2.423

4.  Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

Authors:  Cesare Cremon; Luciana Gargano; Antonio M Morselli-Labate; Donatella Santini; Rosanna F Cogliandro; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Corinaldesi; Giovanni Barbara
Journal:  Am J Gastroenterol       Date:  2009-01-13       Impact factor: 10.864

5.  Epstein-Barr virus and gastric remnant cancer.

Authors:  N Yamamoto; M Tokunaga; Y Uemura; S Tanaka; H Shirahama; T Nakamura; C E Land; E Sato
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

Review 6.  Helicobacter pylori persistence: biology and disease.

Authors:  Martin J Blaser; John C Atherton
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.

Authors:  Kwang Jae Lee; Yeong Bae Kim; Jang Hee Kim; Hoek Chun Kwon; Dong Kyu Kim; Sung Won Cho
Journal:  J Gastroenterol Hepatol       Date:  2008-11       Impact factor: 4.029

8.  Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay.

Authors:  Atsuyoshi Hirano; Hideo Yanai; Norio Shimizu; Takeshi Okamoto; Yoshitaka Matsubara; Kohtaro Yamamoto; Kiwamu Okita
Journal:  Int J Gastrointest Cancer       Date:  2003

9.  "Targeted disruption of the epithelial-barrier by Helicobacter pylori".

Authors:  Lydia E Wroblewski; Richard M Peek
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  6 in total

1.  Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.

Authors:  Nai-Wei Sheu; Shu-Heng Huang; Deng-Chyang Wu; John Y Kao; Kun-Der Lin
Journal:  PLoS One       Date:  2022-05-23       Impact factor: 3.752

Review 2.  The Protective Effects of Helicobacter pylori Infection on Allergic Asthma.

Authors:  Zhi Tong Zuo; Ya Ma; Yan Sun; Cui Qing Bai; Chun Hua Ling; Feng Lai Yuan
Journal:  Int Arch Allergy Immunol       Date:  2020-10-20       Impact factor: 2.749

3.  The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut.

Authors:  Tiffani Alvey Jones; Diane Z Hernandez; Zoë C Wong; Anica M Wandler; Karen Guillemin
Journal:  PLoS Pathog       Date:  2017-10-19       Impact factor: 6.823

Review 4.  Fungi, host immune response, and tumorigenesis.

Authors:  Miar Elaskandrany; Rohin Patel; Mintoo Patel; George Miller; Deepak Saxena; Anjana Saxena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-07       Impact factor: 4.871

Review 5.  Human Gut Microbiota and Gastrointestinal Cancer.

Authors:  Changting Meng; Chunmei Bai; Thomas D Brown; Leroy E Hood; Qiang Tian
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-02-21       Impact factor: 7.691

Review 6.  The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease.

Authors:  Marco Busnelli; Stefano Manzini; Giulia Chiesa
Journal:  Nutrients       Date:  2019-12-27       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.